Intellectual Property UK

  • June 11, 2026

    Philip Morris Wins Dispute Over Rival's 'Aquios' E-Cig TM

    Philip Morris has persuaded European officials to nix a Hong Kong vape seller's "Aquios" trademark, proving that shoppers might think it was linked to the tobacco giant's popular heated tobacco device "Iqos." 

  • June 11, 2026

    Squire Patton Settles £3.7M Claim Over Advice On Tech Deal

    Squire Patton Boggs LLP has settled a claim in a London court that it caused a software company to lose £3.7 million ($4.9 million) through faulty advice on intellectual property ownership in a buyout of a rival.

  • June 11, 2026

    Beats By Dre Can't Mute Audio Retailer's 'Debra' TM In EU

    Beats by Dre has failed to stop a Chinese tech business securing a European Union trademark for its "Debra" sign that contains a "b" icon reminiscent of the Apple subsidiary's own logo.

  • June 10, 2026

    Jellycat Sues Retailer Over Plush Bag Charm Designs

    Jellycat Ltd. has alleged that a London-based handbags and accessories retailer has copied dozens of its anthropomorphic plush toys, infringing its registered designs and damaging its brand.

  • June 10, 2026

    EasyGroup Puts The Brakes On 'Easy-CarTransport' TM

    The owner of the budget airline brand easyJet has persuaded European officials to partially nix a German private equity company's "Easy-CarTransport" trademark, showing that consumers might be confused and think easyGroup was providing rival transport services. 

  • June 10, 2026

    McLaren Can't Lap Software Co. Over Driving Simulator Patent

    McLaren has failed to convince European officials to discard a software engineering company's patent for a realistic driving simulator after an appellate board found a skilled engineer could not rely on earlier designs cited by the premier motorsports team.

  • June 10, 2026

    Rice Producer Loses Appeal To Block Rival Sun TM

    A European court ruled Wednesday that a Bulgarian rice producer could not overturn a decision allowing a rival's stylized sun trademark because its own unregistered logo had been used only for exports, which is not protected under Bulgarian trademark law.

  • June 10, 2026

    Fendi Can't Block Dubai Brand's 'Fares' EU TM

    European officials have rejected Fendi's attempt to block a Dubai fashion brand's composite mark depicting a horse and a stylized geometric figure, concluding that it looks too different from the Italian luxury brand's logo showing two interlocking Fs. 

  • June 10, 2026

    Beverly Hills Polo Club Blocks 'European Polo Champ' TM

    The European Union has blocked a Belgian textile company's "European Polo Champ" trademark application, ruling that consumers could confuse the logo with the Beverly Hills Polo Club clothing brand.

  • June 10, 2026

    UKIPO Moves To Help Universities Protect Their IP

    The U.K. Intellectual Property Office has released a new portfolio of resources designed to help British universities protect and commercialize their intellectual property.

  • June 09, 2026

    Sanofi Drops Amgen UPC Case After Cholesterol Drug Deal

    Europe's patent court has signed off on a joint request from Sanofi, Regeneron and Amgen to dismiss claims that Amgen was infringing on a patented antibody treatment for high cholesterol following a settlement agreement. 

  • June 09, 2026

    Breast Implants Biz Drops UK Infringement Claims At UPC

    A breast implants supplier has dropped its U.K. infringement claims against a rival at the Unified Patent Court, trimming its claims at the European forum after its opponent filed parallel proceedings in a London court.

  • June 09, 2026

    Record Label Wins Bid To Strike Out Rival's Breach Defense

    A London court has told a record label that it must amend its defense against a former business partner's claims of breaching a licensing agreement, ordering it to pay £50,000 ($67,006) to cover the costs of application. 

  • June 09, 2026

    Advanz Expands Challenge To Rival's Bowel Disease Drug IP

    Pharmaceutical company Advanz has expanded its challenge to a rival's protections over the bowel disease drug Entyvio, asking a London court to revoke three additional patents besides the one it had already targeted.

  • June 09, 2026

    Arsenal Can't Net Cannon TM For Toys

    The European Union has trimmed Arsenal FC's application for a trademark covering its famous cannon crest, ruling that the London-based football club cannot exclusively use the logo on toys.

  • June 08, 2026

    Philip Morris Unit Bests BAT Over Tobacco-Free Pouch Patent

    British American Tobacco has failed to convince European officials to scrap a Philip Morris unit's patent for a tobacco-free nicotine pouch after an appellate board found that the company relied on earlier designs that provided different features.

  • June 08, 2026

    US Arms-Maker Accuses UK Rival Of Copying Drone Tech

    A U.S. defense contractor has accused British rival Overwatch Group of deliberately copying its drone design to secure lucrative defense contracts, including one with the U.K. Ministry of Defence.

  • June 08, 2026

    EUIPO Trims TfL Roundel Logo Over Unused Goods

    Transport for London has partially lost protection to use its signature roundel logo for a range of retail services after European officials ruled that the authority failed to provide enough evidence it had really used the design.

  • June 08, 2026

    Icelandic State's Seafood Biz Can't Block 'Icelandium' EU TM

    The European Union has refused to toss a Spanish frozen fish retailer's "Icelandium" trademark application, ruling that there is no risk of confusion with the "Icelandic Seafood" brand that belongs to a state-owned company in Iceland.

  • June 08, 2026

    'Magic Mushroom Cabin' Owners Sue Britvic Over Photo Use

    A couple who let out a hut at their rural home have sued U.K. beverage giant Britvic Soft Drinks Ltd. for infringing on their copyright to a photograph of the cabin, saying their brand is not "naturally aligned" with the beverage maker.

  • June 08, 2026

    Takeda Hits Back At Stada's ADHD Drug IP Challenge

    Takeda has defended the validity of its extended patent protections for ADHD drug Elvanse, asking a London court to reject Stada's attempt to quash a U.K. supplementary protection certificate, or SPC, for the treatment.

  • June 05, 2026

    HP Beats Cartridge Dominance Claim At Top Dutch Court

    The Dutch Supreme Court dismissed an appeal on Friday by a printer cartridge retailer contending that HP has abused its dominant position in the printer cartridge market, after the tech giant barred the shop from selling allegedly infringing cartridges.

  • June 05, 2026

    Dell Blocks Chinese Co.'s 'Delwit' TM In EU

    Dell has persuaded the European Union to block a Chinese company's "Delwit" trademark application, proving that its opponent could take unfair advantage of the computer giant's reputation among shoppers in the bloc.

  • June 05, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the U.K.'s oldest Indian restaurant launch an appeal against King Charles III's property company in an effort to stop its eviction, trustees of a bankrupt former EY tax partner file a claim against his wife, and 37 leading insurers bring a lawsuit against agrichemical company Syngenta over an insurance dispute. Here, Law360 looks at these and other new claims in the U.K.

  • June 05, 2026

    J&J Unit Didn't Properly Serve Drug Patent Claim, US Says

    The U.S. told a London court on Friday that a Johnson & Johnson pharmaceutical unit failed to properly serve a patent revocation claim over a blood cancer treatment, arguing that it did not use the required diplomatic channels.

Expert Analysis

  • How 'Copyleft' Licenses May Affect Generative AI Output

    Author Photo

    Open-source software and the copyleft licenses that support it, whereby derivative works must be made available for others to use and modify, have been a boon to the development of artificial intelligence, but could lead to issues for coders who use AI to help write code and may find their resulting work exposed, says William Dearn at HLK.

  • UPC Decision Highlights Key Security Costs Questions

    Author Photo

    While the Unified Patent Court recently ordered NanoString to pay €300,000 as security for Harvard's legal costs in a revocation action dispute, the decision highlights that the outcome of a security for costs application will be highly fact-dependent and that respondents should prepare to set out their financial position in detail, says Tom Brazier at EIP.

  • IP Ruling Could Pave Way For AI Patents In UK

    Author Photo

    If implemented by the U.K. Intellectual Property Office, the High Court's recent ruling in Emotional Perception AI v. Comptroller-General of Patents, holding that artificial neural networks can be patented, could be a first step to welcoming AI patents in the U.K., say Arnie Francis and Alexandra Brodie at Gowling.

  • Why It's Urgent For Pharma Cos. To Halt Counterfeit Meds

    Author Photo

    With over 10.5 million counterfeit medicines seized in the EU in 2023, it is vital both ethically and commercially that pharmaceutical companies take steps to protect against such infringements, including by invoking intellectual property rights protection, says Lars Karnøe at Potter Clarkson.

  • Examining US And Europe Patent Disclosure For AI Inventions

    Author Photo

    As applicants before the U.S. Patent and Trademark Office and the European Patent Office increasingly seek patent protection for inventions relating to artificial intelligence, the applications may require more implementation details than traditional computer-implemented inventions, including disclosure of data and methods used to train the AI systems, say attorneys at Finnegan.

  • Incontinence Drug Ruling Offers Key Patent Drafting Lessons

    Author Photo

    In a long-awaited decision in Astellas v. Teva and Sandoz, an English court found that the patent for a drug used to treat overactive bladder syndrome had not been infringed, highlighting the interaction between patent drafting and litigation strategy, and why claim infringement is as important a consideration as validity, says George McCubbin at Herbert Smith.

  • EPO Decision Significantly Relaxes Patent Priority Approach

    Author Photo

    In a welcome development for patent applicants, a recent European Patent Office decision redefines the way that entitlement to priority is assessed, significantly relaxing the previous approach and making challenges to the right to priority in post-grant opposition proceedings far more difficult, say lawyers at Finnegan.

  • Why US Should Help European Efforts To Fix SEP Licensing

    Author Photo

    The European Commission's proposed reform of standard-essential patent licensing aims to fix a fundamental problem stemming from the asymmetry and obscurity of information about SEPs, and U.S. agencies exploring regulation of foreign regimes should support and improve these efforts, say David McAdams at Duke University and David Katz at WilmerHale.

  • Shifting From Technical To Clear Insurance Contract Wordings

    Author Photo

    Recent developments on insurance policies, including the Financial Conduct Authority's new consumer duty, represent a major shift for insurers and highlight the importance of drafting policies that actively improve understanding, rather than shift the onus onto the end user, say Tamsin Hyland and Jonathan Charwat at RPC.

  • What's In The Plan To Boost Germany's Commercial Litigation

    Author Photo

    Lawyers at Cleary discuss Germany's recent draft bill, which establishes commercial courts and introduces English as a court language in civil proceedings, and analyze whether it accomplishes the country's goal of becoming a more attractive venue for commercial litigation.

  • Bitcoin Case Highlights Advanced Age Of UK's IP Law

    Author Photo

    An appellate court's recent decision in a case involving the copyright of bitcoin's file format emphasizes the role of copyright protection in software, and also the challenges of applying decades-old laws to new technologies, say Marianna Foerg and Ben Bell at Potter Clarkson.

  • Future Paths For AI Inventorship After Justices' Thaler Denial

    Author Photo

    Anup Iyer at Moore & Van Allen examines the current and future state of AI inventorship in the wake of the U.S. Supreme Court's decision not to hear Thaler v. Vidal, including collaboration, international challenges, and the need for closer examination in research and development-intensive sectors.

  • EU Ruling Highlights Strategic Benefits Of Patent Appeals

    Author Photo

    The European Patent Office board of appeal recently reversed the examining board's ruling in an application by LG Electronics, highlighting how applicants struggling to escape conflicting objection traps at the examination level can improve their chances of a positive outcome with an appeal, says Andrew Rudhall at Haseltine Lake.

  • Series

    In A 'Barbie' World: Boosting IP Value With Publicity Machines

    Author Photo

    Mattel's history of intellectual property monitoring, including its recent challenge against Burberry over the "BRBY" trademark ahead of the "Barbie" film, shows how IP enforcement strategies can be used as publicity to increase brand value and inform potential collaborations, says Carly Duckett at Shepherd and Wedderburn.

  • UPC Revocation Actions Offer An Attractive Patent Strategy

    Author Photo

    As the Unified Patent Court gains momentum after an initial period of nervousness around the recently launched forum, more businesses may be starting to realize the value of running revocation actions as an alternative route to knocking out patents across Europe, say Oliver Laing and Georgia Carr at Potter Clarkson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.